BioOutsource has extensive experience in the development, optimization and qualification of a wide range of different types of binding assays for monoclonal antibodies, and offers GCP, GLP and cGM testing services in compliance with EMA and FDA guidelines to support the biopharmaceutical industry.
BioOutsource offers the following binding assay services:
- ELISA assays
- Electrochemiluminescence (ECL) methods (Mesoscale Discovery (MSD)) assays
- Surface Plasmon Resonance (SPR) assays (Biacore)
BioOutsource offers cost-effective solutions to develop custom methods to support development of monoclonal antibodies. Please contact us to discuss your specific project.